University of Turku researchers have developed sensors from single-wall carbon nanotubes for continuous health monitoring.
The FDA has approved Valcare Medical’s IDE application, allowing it to begin an EFS of Amend Trans-Septal System.
Eye cancer is rare, accounting for less than 1% of all new cancer cases in the UK. Image credit: Leonardo Gabriel Tallone via ...
A day after announcing a business split-off to focus on weight loss and diabetes implants, Vivani Medical has implanted the ...
The US Food and Drug Administration (FDA) has cleared Perfuze’s Zipline access catheter for acute ischemic stroke (AIS) ...
Proteomics International Laboratories has launched the PromarkerD diabetic kidney disease (DKD) predictive test in Australia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results